Skip to main content

and
  1. No Access

    Article

    Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines

    The multifunctional protein - tissue inhibitor of metalloproteinases-1 (TIMP-1) - has been associated with a poor prognosis in several types of cancers including glioblastomas. In addition, TIMP-1 has been ass...

    Charlotte Aaberg-Jessen, Louise Fogh, Mia Dahl Sørensen in Pathology & Oncology Research (2019)

  2. Article

    Open Access

    Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas

    We have previously identified tissue inhibitor of metalloproteinases-1 (TIMP-1) as a prognostic marker in glioblastomas. TIMP-1 has been associated with chemotherapy resistance, and CD63, a known TIMP-1-bindin...

    Charlotte Aaberg-Jessen, Mia D. Sørensen, Ana L. S. A. Matos, José M. Moreira in BMC Cancer (2018)

  3. Article

    Open Access

    Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo

    Glioblastoma is the most frequent and most malignant brain tumor with the patients having a median survival of only 14.6 months. Although glioblastoma patients are treated with surgery, radiation and chemother...

    Stine S. Jensen, Stine A. Petterson, Bo Halle, Charlotte Aaberg-Jessen in BMC Cancer (2017)

  4. Article

    Open Access

    Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

    Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been associated with poor prognosis and resistance towards chemotherapy in several cancer forms. In a previous study we found an association between a low ...

    Charlotte Aaberg-Jessen, Bo Halle, Stine S. Jensen in Journal of Neuro-Oncology (2016)

  5. No Access

    Article

    Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures

    Glioblastomas always recur despite surgery, radiotherapy and chemotherapy. A key player in the therapeutic resistance may be immature tumor cells with stem-like properties (TSCs) esca** conventional treatmen...

    Bo Halle, Mads Thomassen, Ranga Venkatesan, Vivek Kaimal in Journal of Neuro-Oncology (2016)

  6. No Access

    Article

    Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept

    Over-expressed microRNAs (miRs) are promising new targets in glioblastoma (GBM) therapy. Inhibition of over-expressed miRs has been shown to diminish GBM proliferation, invasion and angiogenesis, indicating a ...

    Bo Halle, Eric G. Marcusson, Charlotte Aaberg-Jessen in Journal of Neuro-Oncology (2016)

  7. No Access

    Article

    Effects of Chemotherapeutics on Organotypic Corticostriatal Slice Cultures Identified by A Panel of Fluorescent and Immunohistochemical Markers

    Effects of chemotherapeutics on glioma cell lines and spheroids are usually investigated without evaluating the effects of chemotherapeutics on normal brain tissue. To perform such investigations, the aim of t...

    Annette Nørregaard, Stine Skov Jensen, Jesper Kolenda in Neurotoxicity Research (2012)

  8. No Access

    Chapter

    Primary Glioma Spheroids: Advantage of Serum-Free Medium

    In the field of cancer research, in vitro models are widely used to investigate tumor biology as well as new experimental treatments. There is a need to improve these models, making them more in vivo-like, in ...

    Charlotte Aaberg-Jessen, Karina Christensen in Stem Cells and Cancer Stem Cells, Volume 1 (2012)

  9. No Access

    Article

    Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids

    Tumor hypoxia has been attributed to play a crucial role in tumorigenesis and therapeutic resistance. Recently, it has been suggested that hypoxia leads to and maintains the undifferentiated state of tumor ste...

    Jesper Kolenda, Stine Skov Jensen, Charlotte Aaberg-Jessen in Journal of Neuro-Oncology (2011)

  10. No Access

    Article

    Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival

    In colorectal cancer and breast cancer a high TIMP-1 level has been shown to correlate with a shorter overall patient survival and it has been suggested that TIMP-1 is involved in tumour invasion, proliferatio...

    Charlotte Aaberg-Jessen, Karina Christensen, Hanne Offenberg in Journal of Neuro-Oncology (2009)